Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2381 of 6351
-
Heart timing test may spot hidden vessel disease
Diagnosis Recruiting nowThe project is aimed at studying the feasibility of mechanical dyssynchrony of the left ventricle of the heart, determined by SPECT (gated MPI), as well as its stress-induced dynamics, in the evaluation of patients with coronary microvascular dysfunction in chronic coronary heart…
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New heart bypass approach could mean faster recovery for patients
Disease control By invitation onlyThe objective of this study is to evaluate the safety and feasibility of Minimally Invasive Coronary Artery Bypass surgery in selected patients ,with multi vessel coronary disease. This trial is designed to be a pilot study that will gather comparative information on the clinica…
Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Digital checklist aims to prevent oxygen emergencies in 3,000 kids
Knowledge-focused Recruiting nowThe purpose of the study is to implement a patient-provider dyad tailored, Electronic Health Record (EHR)-informed, digitized Smart Checklist as a Quality Improvement (QI) intervention to support bedside clinician teams to reduce Adverse Airway Outcomes (AAO) across 6 diverse ped…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
AI reads biopsies to spot Sjogren's syndrome
Diagnosis CompletedThe aim of this research is to discover an artificial intelligence (AI) algorithm for lymphocyte focus score in whole slide images of labial minor salivary gland (SG) biopsy samples for diagnosing Sjogren's Syndrome, in order to enhance the precision of pathological interpretatio…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
Can molecular markers revolutionize adrenal cancer management?
Knowledge-focused Recruiting nowThe adrenal cancer research network "COMETE" is federating French research on rare adrenal cancers. COMETE achieved major breakthroughs in the molecular characterization of adrenocortical carcinomas (ACC) and malignant pheochromocytomas/paragangliomas (MPP). Recently, COMETE succ…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Viagra-Like drug may boost IVF success in unexplained infertility
Symptom relief Recruiting nowinvestigate the effect of different vasodilators as Tadalafil in women with unexplained infertility using IVF
Phase 4 • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Remote tai chi may keep seniors on their feet
Prevention Recruiting nowTo examine two different exercise programs in reducing incidence of falls among community-dwelling older adults
Sponsor: Oregon Research Institute • Aim: Prevention
Last updated Jun 27, 2026 09:02 UTC
-
Eye test could reveal hidden brain changes years before Alzheimer's symptoms
Knowledge-focused By invitation onlyYears before someone experiences the symptoms of Alzheimer's disease, a compound called amyloid beta (Aβ) builds up in the brain. Excess Aβ - directly or indirectly - causes many of the symptoms of Alzheimer's dementia. However, recent studies of the FDA-approved drugs lecanemab …
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Could a sleep apnea drug boost brain power in kids with down syndrome?
Symptom relief OngoingThis is an open-label study of the combination of atomoxetine and oxybutynin (ato-oxy) in children with Down syndrome and obstructive sleep apnea (OSA) documented by polysomnography (PSG). Participants will receive ato-oxy for 6 months. Ato-oxy dose will be 5 mg oxybutynin and 0.…
Phase 2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Scientists probe why endometriosis hurts so much
Knowledge-focused Recruiting nowAim 1. To determine the factors contributing to pain in patients with chronic pelvic pain with and without endometriosis Aim 2. To determine the changes following endometriosis lesion removal surgery in pain and sex hormone levels. Aim 3. To identify factors predicting clinical …
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New combo therapy targets hard-to-treat GIST tumors
Disease control Recruiting nowThis is a Phase 1/2, multicenter, open-label (unless otherwise specified in a combination-specific module) study of inlexisertib in combination with anticancer therapies. Modules within the master protocol are defined according to different combinations of inlexisertib with other…
Phase 1/2 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Immune cell study could unlock new COVID-19 treatments
Knowledge-focused CancelledThe purpose of this study is to analyze in depth the relationship of myeloid cell subpopulations during infection by Severe acute respiratory syndrome coronavirus 2 (SARS-Cov2), the virus mediating Covid-19. Myeloid cells include neutrophils, monocytes and dendritic cells, each d…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Promising breast cancer drug tested in resistant patients – but trial cut short
Disease control Stopped earlyThe goal of this national, multicenter single arm phase II clinical trial is to study the efficacy, safety and tolerability of the administration of Trastuzumab Deruxtecan (T-DXd) in HER2-positive locally advanced or metastatic breast cancer (MBC) patients resistant to trastuzuma…
Phase 2 • Sponsor: Spanish Breast Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug SG1827 enters first human tests for Hard-to-Treat cancers
Disease control CompletedThis is a Phase I, open-label, dose escalation and dose expansion study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SG1827 in subjects with Advanced Solid Tumors, refractory or resistant to standard therapy, or without available standard or curative therapy.
Phase 1 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Liver cancer drug combo vs. local therapy: trial ends early
Disease control Stopped earlyThe purpose of this research study is to compare the effectiveness and safety of two standard of care treatments in people who have been diagnosed with hepatocellular carcinoma (HCC).This research study is being done to compare atezolizumab/bevacizumab to locoregional therapy wit…
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Exercise as medicine: new trial tests group workouts for mental health
Disease control OngoingThe goal of this clinical trial is to compare Braining, a physical exercise lifestyle intervention in psychiatric care, with structured advice on physical exercise. The main questions are: * does Braining lead to increased physical exercise compared to structured advice on phys…
Sponsor: Region Stockholm • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New device aims to improve healing after heart surgery
Disease control OngoingThe goal of this clinical trial is to compare the safety and performance of the sternal stabilization system STERN FIX with the standard of care (sternal closure with wires only) in normal conditions of use, in patients of risk undergoing median sternotomy during cardiothoracic s…
Sponsor: NEOS Surgery • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Brain injury study seeks to sharpen thinking with smartphone reminders
Knowledge-focused Recruiting nowThe goal of this clinical trial is to investigate predictors of treatment outcome, and the effect of individual treatment components of Goal Management Training (GMT) for improvement of cognitive control function in people with acquired brain injury (ABI). Primary aim: To identi…
Sponsor: St. Olavs Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New care approach aims to help seniors bounce back after colon cancer surgery
Symptom relief Recruiting nowHealth establishments encourage the development of specific care pathways for the elderly by supporting Geriatric Peri-Operative Units (GPOU). Indeed, this shared care model has shown a clear reduction in mortality and the number of re-hospitalizations in patients 6 months after …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New cancer drug JS207 enters first human tests
Disease control OngoingThis is a Phase I open-label, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK),Pharmacodynamic characteristics, immunogenicity and antitumor activity of JS207 in patients with advanced malignant tumor. The Recommended dose for phase II trial (RP2D) wi…
Phase 1 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC